Mary Kwok MD

Education

MD, Uniformed Services University of the Health Sciences, Bethesda, MD, 2006
BS, Biochemistry, University of Washington, Seattle, WA, 2001
BA, Anthropology, University of Washington, Seattle, WA, 2001

Career Highlights: Positions, Projects, Deployements, Awards and Additional Publications

Clinical Director, Multiple myeloma service, Fred Hutchinson Cancer Center, Seattle, WA, 2024 - present

Associate Professor of Clinical Practice, University of Washington, Seattle, WA, 2020 - present

Associate Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, 2018 - present

Fellowship Program Director, National Capitol Consortium, Bethesda, MD, 2018 - 2020

Walter Reed National Military Medical Center, Military Treatment Facility Teacher of the Year, 2019

Battalion Surgeon, 1-41 Infantry Battalion in support of Operation Enduring Freedom, May-Sep 2014

James J. Leonard for Excellence in Teaching Internal Medicine, 2014

Representative Bibliography

Cicero KI, Banerjee R, Kwok M, Dima D, Portuguese AJ, Chen D, Chalian M, Cowan AJ. Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions. Diagnostics (Basel). 2025 Jan 18;15(2):215.

Lee K, Paek H, Huang LC, Hilton CB, Datta S, Higashi J, Ofoegbu N, Wang J, Rubinstein SM, Cowan AJ, Kwok M, Warner JL, Xu H, Wang X. SEETrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical Trials. medRxiv [Preprint]. 2024 May 13:2024.

Kosydar S, Gulhane A, Libby E, Cowan AJ, Kwok M, Lee SS, Green DJ, Coffey D, Holmberg LA, Chen DL, Tseng YD. Radiographic Response of Solitary Plasmacytomas After Conformal Radiotherapy May Be Delayed: Outcomes in the 3D Era. Am J Clin Oncol. 2022 Nov 1;45(11):443-449.

Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libbey EN. Diagnosis and Management of Multiple Myeloma: A Review. JAMA. 2022 Feb 1; 327(5):464-477.

Kazandjian D, Hill E, Dew A, Morrison C, Roswarski J, Korde N, Emanuel M, Petrosyan A, Bhutani M, Calvo KR, Dulau-Florea A, Kwok M, Lee MJ, Lee S, Lindenberg L, Mailankody S, Manasanch E, Maric I, Mena E, Patel N, Tageja N, Trepel JB, Turkbey B, Wang HW, Wang W, Yuan C, Zhang Y, Braylan R, Choyke P, Stetler-Stevenson M, Steinberg SM, Figg WD Sr, Roschewski M, Landgren O. Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial. JAMA Oncology. 2021 Nov 1;7(11):1678-1685.

Cowan AJ, Stevenson PA, Green DJ, Tuazon S, Libby EN, Kwok M, Lee S, Coffey DG, Gopal AK, Holmberg LA. Prolonged Lenalidomide therapy does not impact autologous peripheral blood stem cell mobilization and collection in multiple myeloma patients: a singe- center retrospective analysis. Transplant Cell Ther. 2021 Aug;27(8):661.e1-e6.

Kazandjian D, Hill E, Hultcrantz M, Rustad EH, Yellapantula V, Akhlaghi T, Korde N, Mailankody S, Dew A, Papaemmanuil E, Maric I, Kwok M, Landgren O. Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients. Blood Cancer J. 2019 Feb 4;9(2):15.

Dosani T, Mailankody S, Korde N, Manasanch E, Bhutani M, Tageja N, Roschewski M, Kwok M, Kazandjian D, Costello R, Burton D, Zhang Y, Liewehr D, Steinberg SM, Maric I, Landgren O. Host-related immunodeficiency in the development of multiple myeloma. Leuk Lymphoma. 2018 May;59(5):1127-1132. PMID: 28792255.

Korde N, Zhang Y, Loeliger K, Poon A, Simakova O, Zingone A, Costello R, Childs R, Noel P, Silver S, Kwok M, Mo C, Young N, Landgren O, Sloand E, Maric I. Monoclonal gammopathy-associated pure red cell aplasia. Br J Haematol. 2016 Jun;173(6):876-83. PMID: 26999424.

Korde N, Roschewski M, Zingone A, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Wu P, Morrison C, Costello R, Zhang Y, Burton D, Mulquin M, Zuchlinski D, Lamping L, Carpenter A, Wall Y, Carter G, Cunningham SC, Gounden V, Sissung TM, Peer C, Maric I, Calvo KR, Braylan R, Yuan C, Stetler-Stevenson M, Arthur DC, Kong KA, Weng L, Faham M, Lindenberg L, Kurdziel K, Choyke P, Steinberg SM, Figg W, Landgren O. Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma. JAMA Oncol. 2015 Sep 1;1(6):746-54. PMID: 26181891.